CLINICAL_TRIALS
trial_result
· 2015-10-05
Clinical Trial Update: A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 study results update evaluating trastuzumab (Herceptin) with biomarker-guided approaches in patients with HER2-positive metastatic breast cancer. Result…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-10-05